Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Frontiers | The Safety and Efficacy of Stem Cell Therapy as an Emerging Therapy for ALS: A Systematic Review of Controlled Clinical Trials
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis | Journal of Medicinal Chemistry
State of play in amyotrophic lateral sclerosis genetics | Nature Neuroscience
Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation | Nature Reviews Drug Discovery
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies | Nature Reviews Genetics
Cells | Free Full-Text | The NF-κB Pathway and Cancer Stem Cells
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Cells | Free Full-Text | Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
Gene therapy for ALS: A review: Molecular Therapy
Cells | Free Full-Text | The Regulation of NF-κB Subunits by Phosphorylation
JCM | Free Full-Text | Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
IJMS | Free Full-Text | The Links between ALS and NF-κB
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling | Journal of Neuroscience
GSK-3β controls NF-kappaB activity via IKKγ/NEMO | Scientific Reports
Frontiers | Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers | Nature Reviews Neurology
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS | The EMBO Journal
Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies
Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
Frontiers | Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
Frontiers | Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence | Scientific Reports
Cells | Free Full-Text | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
